Tango Therapeutics founder Barbara Weber has retired as president and chief executive of the clinical-stage biotechnology company. Tango on Thursday said Malte Peters, a board member since 2018, will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback